Francois Cedric
SEC insider (Form 3/4/5 filer). CIK 0001658080. Chief Executive Officer at Apellis Pharmaceuticals, Inc. (APLS). 39 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in WALTHAM, MA.
Companies Francois Cedric has filed insider reports for
- Apellis Pharmaceuticals, Inc. (APLS): Director, Officer, Chief Executive Officer
Francois Cedric
CIK: 0001658080
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Apellis Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (39 total)
- May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect87.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect87.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
Tender OfferIndirect234.4K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect143.8K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect143.8K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
Tender OfferDirect426K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
Tender OfferIndirect372.8K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
Tender OfferIndirect472.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
Tender OfferIndirect300K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect98K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 87,108 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 87,108 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Tender Offer | 234,411 | - | $0 | Indirect |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 143,750 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 143,750 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Tender Offer | 425,968 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Tender Offer | 372,815 | - | $0 | Indirect |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Tender Offer | 472,065 | - | $0 | Indirect |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Tender Offer | 300,000 | - | $0 | Indirect |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 97,976 | - | $0 | Direct |
1-10 of 39 transactions